Article Information
History
- February 25, 2022.
Article Versions
- Version 1 (September 14, 2021 - 11:28).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jennifer R. Richardson,
- Ralph Götz,
- Vanessa Mayr,
- Martin J. Lohse,
- Hans-Peter Holthoff* and
- Martin Ungerer*
- ↵*Correspondence to: Prof. Martin Ungerer, MD, or to Hans-Peter Holthoff, PhD, ISAR Bioscience, Semmelweisstrasse 5, D 82152 Planegg, Germany; martin.ungerer{at}isarbioscience.de; hans-peter.holthoff{at}isarbioscience.de
Posted February 25, 2022.
SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection
